 HOLLISTER, Calif., Oct. 26, 2022 GLOBE NEWSWIRE -- Alpha Teknova, Inc. Teknova Nasdaq: TKNO, a leading provider of critical reagents for the discovery, development, and commercialization of drug therapies, novel vaccines, and molecular diagnostics, today announced that the Company will report its financial results for the third quarter ended September 30, 2022, on Wednesday, November 9, 2022, following the close of market. 